04:42 PM EDT, 09/08/2025 (MT Newswires) -- Eben Tessari, Chief Operating Officer, on September 04, 2025, sold 98,660 shares in Kiniksa Pharmaceuticals International ( KNSA ) for $3,506,278. Following the Form 4 filing with the SEC, Tessari has control over a total of 44,452 Class A ordinary shares of the company, with 44,452 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1730430/000141588925023878/xslF345X05/form4-09082025_080944.xml